The CT linac based Radixact System offers multiple radiation delivery options to tailor each patient's treatment based on their specific needs. The system's extensive capabilities make it possible for clinicians to treat breast cases in as little as 2 minutes. With TomoHelical™ mode, the Radixact System continuously delivers radiation beams from 360 degrees around the patient, enabling the treatment of complex cases, such as cancer in the breast and surrounding lymph nodes. This approach also provides a valuable option for patients who are unable to hold their breath, which is key to undergoing DIBH treatments. TomoDirect mode facilitates delivery of radiation from specific fixed angles.
According to the National Cancer Institute, breast cancer is the most common cancer diagnosed in women in the U.S., other than skin cancers1. Radiation therapy plays a crucial role in the management of early-stage, locally advanced, and metastatic breast cancer cases. It is utilized in approximately 87 percent of breast cancer patients2 and accounts for more than 25 percent of cases in most radiation therapy departments3.
Ad Statistics
Times Displayed: 112448
Times Visited: 6718 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
The Radixact® System with its unique radiation delivery approaches offers advantages in the treatment of breast cancer including the ability to deliver precise radiation dose to any tumor bed, during every treatment, while minimizing dose to nearby healthy organs and tissues. With the Radixact System, radiation therapy may be an option for treating breast cancer at almost every stage and can be used after surgery, chemotherapy and other medications.
About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, Twitter, and YouTube.
Back to HCB News
